Navigation Links
Numira Biosciences Names New Board Member
Date:8/11/2011

SALT LAKE CITY, Aug. 11, 2011 /PRNewswire/ -- Numira Biosciences, a specialty contract research organization and leader in high resolution, 3D imaging services and visualization software for the life science market, today announced that it has appointed William M. Harrison to its Board of Directors.

Mr. Harrison currently serves as the Chief Executive Officer at VIDA Sciences, a CRO consulting firm based in Kalamazoo, Michigan.  Prior to founding VIDA Sciences, Mr. Harrison held a number of senior management positions at MPI Research, a large international CRO based in Mattawan, Michigan.  Most notably, during his last ten years at MPI, he held the position of President and Chief Operating Officer. Additionally, Mr. Harrison is an active member of the Society of Quality Assurance and serves on the Board of Trustees for the Kalamazoo Valley Community College Foundation and the Borgess Medical Center, as well as serving as a board member for the American Life Sciences Innovation Council.

"We are pleased that Bill has joined our board," said Michael Beeuwsaert, President and CEO of Numira. "His 25 years of senior management and regulatory compliance experience in a high-growth, preclinical services environment will be of great value to Numira as we move to the next level as a company."

About Numira Biosciences

Numira is a rapidly growing provider of specialty contract research services to the pharmaceutical and medical device industries.  Through the combination of several novel technologies and capabilities, we provide clients with an unmatched array of pre-clinical services for their research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other areas of disease and/or therapy.  Moreover, we are a recognized leader in high-resolution, quantitative imaging for drug and device development.  Numira, a privately-held company, is venture-backed by vSpring Captital, the Tech Coast Angels, and Crocker Ventures.   For more information on Numira, please visit www.numirabio.com.


'/>"/>
SOURCE Numira Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
2. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
3. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
4. Neurocrine Biosciences Reports Second Quarter 2011 Results
5. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
6. Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology
7. Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast
8. Cell Biosciences Changes Name to ProteinSimple
9. Sofie Biosciences is Awarded a DOE Phase I SBIR to Commercialize Microscale Radiochemistry Platform
10. SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools
11. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
Breaking Biology News(10 mins):